Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 18

Results For "Citi"

770 News Found

Alkem signs license agreement with Takeda to commercialise Vonoprazan in India
News | September 04, 2024

Alkem signs license agreement with Takeda to commercialise Vonoprazan in India

Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)


Siegfried opens quality control lab in Minden
News | September 04, 2024

Siegfried opens quality control lab in Minden

The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant


India's bioeconomy to reach US $300 billion by 2030: Dr. Jitendra Singh
Policy | August 27, 2024

India's bioeconomy to reach US $300 billion by 2030: Dr. Jitendra Singh

The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come


Aster DM Healthcare launches Tele ICU Services in India
News | August 22, 2024

Aster DM Healthcare launches Tele ICU Services in India

The tele-icu services which had a soft launch four months ago have already provided valuable assistance to 250+ patients in some of the remotest villages in India


Antara AGEasy celebrates one year of advancing senior health solutions
Healthcare | August 21, 2024

Antara AGEasy celebrates one year of advancing senior health solutions

AGEasy has made significant strides in addressing the pressing health concerns of seniors in India


Generative AI is a top driver for cloud investments: Wipro FullStride Cloud Report
Digitisation | August 15, 2024

Generative AI is a top driver for cloud investments: Wipro FullStride Cloud Report

Majority of organizations are looking to increase investments in public and hybrid cloud


Jan Aushadhi Kendras have sold Rs. 5,600 Cr medicines over last 10 years
Policy | August 10, 2024

Jan Aushadhi Kendras have sold Rs. 5,600 Cr medicines over last 10 years

The sales of medicines and other items sold through Jan Aushadhi Kendras have increased from Rs. 7.29 crore in 2014 to Rs. 1,470 crore by July 2024


India emerging as world-class cost-effective healthcare destination and global pharma leader: Dr. Jitendra Singh
Policy | August 07, 2024

India emerging as world-class cost-effective healthcare destination and global pharma leader: Dr. Jitendra Singh

He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries


SMS Pharmaceuticals reports Q1 FY25 consolidated PAT at Rs. 16.48 Cr
News | August 06, 2024

SMS Pharmaceuticals reports Q1 FY25 consolidated PAT at Rs. 16.48 Cr

SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024